China Pharma Holdings, Inc.CPHINYSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank13
3Y CAGR-3.4%
5Y CAGR-7.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-3.4%/yr
vs -13.0%/yr prior
5Y CAGR
-7.9%/yr
Recent acceleration
Acceleration
+9.6pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$2.67M+15.5%
2024$2.31M+3.0%
2023$2.25M-24.2%
2022$2.96M-5.8%
2021$3.15M-22.1%
2020$4.04M-13.0%
2019$4.64M-10.1%
2018$5.17M-5.7%
2017$5.48M-13.0%
2016$6.30M-